key: cord-1039829-hyp3f1vl authors: Liu, Shuo; Han, Jing; Puyal, Estela Laporta; Kontaxis, Spyridon; Sun, Shaoxiong; Locatelli, Patrick; Dineley, Judith; Pokorny, Florian B.; Costa, Gloria Dalla; Leocani, Letizia; Guerrero, Ana Isabel; Nos, Carlos; Zabalza, Ana; Sørensen, Per Soelberg; Buron, Mathias; Magyari, Melinda; Ranjan, Yatharth; Rashid, Zulqarnain; Conde, Pauline; Stewart, Callum; Folarin, Amos A; Dobson, Richard JB; Bailón, Raquel; Vairavan, Srinivasan; Cummins, Nicholas; Narayan, Vaibhav A; Hotopf, Matthew; Comi, Giancarlo; Schuller, Björn; Consortium, RADAR-CNS title: Fitbeat: COVID-19 Estimation Based on Wristband Heart Rate Using a Contrastive Convolutional Auto-Encoder date: 2021-10-26 journal: Pattern Recognit DOI: 10.1016/j.patcog.2021.108403 sha: 8467316ea88b3661f6146c0a841be5b5e84a3277 doc_id: 1039829 cord_uid: hyp3f1vl This study proposes a contrastive convolutional auto-encoder (contrastive CAE), a combined architecture of an auto-encoder and contrastive loss, to identify individuals with suspected COVID-19 infection using heart-rate data from participants with multiple sclerosis (MS) in the ongoing RADAR-CNS mHealth research project. Heart-rate data was remotely collected using a Fitbit wristband. COVID-19 infection was either confirmed through a positive swab test, or inferred through a self-reported set of recognised symptoms of the virus. The contrastive CAE outperforms a conventional convolutional neural network (CNN), a long short-term memory (LSTM) model, and a convolutional auto-encoder without contrastive loss (CAE). On a test set of 19 participants with MS with reported symptoms of COVID-19, each one paired with a participant with MS with no COVID-19 symptoms, the contrastive CAE achieves an unweighted average recall of [Formula: see text] , a sensitivity of [Formula: see text] and a specificity of [Formula: see text] , an area under the receiver operating characteristic curve (AUC-ROC) of 0.944, indicating a maximum successful detection of symptoms in the given heart rate measurement period, whilst at the same time keeping a low false alarm rate. contrastive learning, convolutional auto-encoder Remote passive monitoring of physiological and behavioural characteristics using smartphones and wearable devices can be used to rapidly collect a variety of data in huge volumes with minimal effort from the wearer. Such data has the potential to improve our understanding of the interplay between a variety of health conditions at individual and population level, if rigorously collected and validated [1] . Passive data collection is typically implemented with a high temporal resolution [2] . Wearable fitness trackers, for example, estimate parameters such as heart rate up to every second and up to 24 hours a day. Monitoring individuals with a range of health states, lifestyles, and demographic variables in combination with data artefacts and missing data leads to high variability, while multiple data streams, from heart rate and physical activity to GPS-based location, can be collected. Therefore, studies using wearables and smartphones in this way exhibit several vs of big data: velocity, volume, variability and variety. As such, advanced analysis methodologies such as deep learning can potentially make a significant contribution [3] , particularly in the context of infectious diseases, such as COVID-19, the disease caused by the novel corona virus (SARS-CoV-2). Specific applications include individual screening and population-level monitoring that minimise contact with infected individuals [4, 5] . Since the outbreak of the COVID-19 pandemic in 2020, several deep learning methodologies have been applied to computed tomography (CT) scans [6] and 2D X-ray images [7] to detect COVID-19. These methods require specific clinical equipment and the patient must attend a clinical facility. Consequently, it cannot achieve early, automatic detection when COVID-19 symptoms first appear. In contrast, heart rate can be measured remotely and non-intrusively using wearable devices. Heart rate is a biomarker of particular value in such applications. Patterns in heart rate fluctuations over time have been found to provide clinically relevant information about the integrity of the physiological system generating these dynamics. Previous studies have not only revealed an altered heart rate variability in a number of medical conditions [8] , but also demonstrated that the degree of short-term heart rate alteration correlates with illness severity. Analysis of the autonomic regulation of heart rate has also been discussed as a promising approach for detecting infections earlier than conventional clinical methods and making prognoses [9] . Wearables such as Fitbit fitness trackers 1 provide indirect measurements of the heart rate through pulse rate estimates made using photoplethysmography (PPG). In the ongoing DETECT 2 study [5] , researchers are focusing on monitoring outbreaks of viral infections including COVID-19 based on the resting heart rate collected in this way [10] . Other similar ongoing endeav- Applied to such data sets, deep learning has the potential to automatically identify individuals with COVID-19 purely on the basis of data passively acquired by means of wearable devices [5, 11, 12] . To the best of our knowledge, the present study is the first to compare deep learning approaches in predicting the presence or absence of COVID-19-like symptoms using Fitbitmeasured heart rate data. We aim to exploit state-of-the-art methods to represent the problem by feature maps, including convolutional neural networks (CNNs) and a convolutional auto-encoder (CAE) [13] . Considering the deficiency of class information in training a standard CAE, in some previous works, the class information was applied to latent attribute layers, leading to the supervised auto-encoder introduced in [14] . Cross-entropy losses are used to minimise the difference between predicted labels from latent attributes and true labels. This approach provides a certain preservation of the reconstructed feature map, taking the cross-entropy loss as a regularisation method. The reconstruction error and cross entropy loss are jointly optimised. However, the optimisation of the joint loss requires a proper combination factor in order to balance the optimisation on reconstruction error and prediction error. Since the two types of errors originate from different stages of the auto-encoder model, leading to their different scale level, the difficulty lies in seeking a good combination scale. To circumvent this problem, we consider the task at hand as analogous to anomaly detection [15] and propose a self-supervised training strategy by means of fitting the reconstruction error into the format of contrastive loss [16] instead of conventional loss like root mean square error (RMSE). In this way, contrastive loss can be employed directly on the reconstruction error for positive and negative input pairs. The method also enables validation of whether the model has learnt discriminative latent attributes for different classes in the auto-encoder framework. We investigate the effectiveness of the proposed technique, comparing its performance to a CAE without contrastive loss, in addition to other standard deep learning methods including a multi-layer perceptron (MLP), a long short-term memory (LSTM) neural network, and a conventional CNN [13] . Recent work has investigated data streams that could potentially be used to detect COVID-19 and can be easily captured using smart devices and wearable equipment [17, 18] , including recordings of coughing and breathing [19] and speech signals [20, 21] . Un et al. [22] proposed a machine learning-derived index reflecting overall health status of the patients with mild COVID-19, using the data captured from wearable biosensors. Hirten and colleagues [23] performed an evaluation of heart rate variablity (HRV) collected by a wearable device to identify and predict COVID-19 and its related symptoms. Radin and colleagues [4] analysed the resting heart rate alongside with sleep duration data in over 47 000 individuals to improve model predictions of influenza rates in five US states. Quer et al. [5] and Mishra et al. [12] have shown the potential of using heart rate, sleep duration, and activity data, retrieved from smart wearable devices for COVID-19 recognition. Natarajan and colleagues [11] used a CNN to predict illness on a given day using Fitbit data from 1 181 individuals, reporting an area under the receiver operating characteristics curve (AUC-ROC) of 0.77 ± 0.03. This paper describes a deep learning approach applied to Fitbit measurement of heart rate to predict the presence or absence of COVID-19-like symptoms. We explore the suitability of using a CAE with contrastive loss, expecting to learn feature representations by contrasting symptomatic and asymptomatic samples. Contrastive learning has already been applied to detect COVID-19 from CT scans or X-ray images as in [24] and [25] . By using contrastive learning for a CAE, we aim to incorporate the class information into its reconstruction error to assist the model in achieving more differentiable latent attributes, and reaching sufficient distance between the reconstruction errors of symptomatic and asymptomatic samples. The data used in this work was collected as part of the IMI2 RADAR-CNS 7 programme 5 , which is currently being conducted at multiple clinical sites in several European countries. Participant recruitment and data collection in the RADAR-MS study started in June 2018. As of March 1, 2020, 499 participants had been enrolled and 403 (81 %) remained in the study [26] . Heart rate data was collected continuously 24-hours-a-day/7-days-a-week using a Fitbit wristband combined with participants' own Android smartphones where available, or a provided Motorola G5, G6, or G7. Fitbit Charge 2 or Charge 3 devices were provided to participants, who were asked to wear the device on their non-dominant hand. Meanwhile, an app-based questionnaire was distributed to all active participants on March 25 2020 and again on April 8 2020. By April 15 2020, at least one of the questionnaires was completed by 399 participants (99 %). We used two definitions to determine the prevalence of COVID-19 in participants [26] : In the first, referred to as CD1, participants experience fever or anosmia/ageusia in combination with any other COVID-19 symptoms including respiratory symptoms, tiredness and gastrointestinal symptoms, or respiratory symptoms plus two other COVID-19 symptoms. In the second definition, CD2, participants experience fever plus any other COVID-19 symptoms, or respiratory symptoms plus anosmia/ageusia. Laboratoryconfirmed cases are included in both case definitions [26] . We considered Fitbit heart rate measurements made between 21 Febru-5 https://www.radar-cns.org/ Red rectangle -7 days heart rate data before and after symptom onset representing a symptomatic segment; green rectangleasymptomatic segment. Middle: Symptomatic segment. Blue curve -unprocessed heart rate trajectory of the red rectangle above; red curve -heart rate trajectory averaged over 5-minutes intervals. Bottom: Representation of the symptomatic segment as 24 × 168 sized image of 5-minutes heart rate data related pixels. Each column represents an interval of 2 hours, the 168 columns sum up to 14 days. Heart rate data of the participants were assigned into temporal segments, defining a 14-day interval extending from 7 days preceding symptom onset to 7 days following symptom onset in which we sought to identify infectionrelated variations in heart rate. The interval mainly covers the duration of the COVID-19 incubation period [28] , and minimises the anomalous effects of day-to-day variations in activity, such as those observed between weekdays and weekends. Fig. 1 demonstrates the segmentation and subsequent data pre-processing procedure for the heart rate data of a participant with reported COVID-19like symptoms. A heart rate segment over 14 days centred at 00:00 at the day of reported symptom onset, i. e., 7 consecutive days before the day of reported symptom onset plus 7 consecutive days starting with the day of reported symptom onset (red box on top of Fig. 1 ) is referred to as symptomatic segment. In contrast, an asymptomatic segment stands for any 14-days interval of consecutive heart rate data again starting at 0 o'clock that is at least An overview of available symptomatic and asymptomatic segments is given in Table 2 . Instantaneous heart rate estimates were derived from the PPG signal and ideally uploaded every five seconds (blue curve in the middle of Fig. 1 ). The mean of 5 minutes is taken to smooth heart rate measurements while still tracking slow short-term changes in the heart rate. Moreover, this approach alleviates the effect of different sampling rates of heart rate measures in Fitbit data, and missing estimates observed in real living conditions, both of which making it very difficult to study other features than mean heart rate in 5-minutes intervals. Furthermore, 5 minutes represents the time interval usually recommended for short-term heart rate variability analysis, assuming a constant mean heart rate (HRV). Missing data over full 5-minutes intervals was filled with the median value of the overall 14-days segment, which guarantees for more robustness against outliers as compared to the mean value. Finally, we have a single heart rate value every 5 minutes. Despite the high completeness of heart rate segments (see Table 2 ), the missing data can be potentially spread over an entire heart rate segment. A too small short-term duration leads to more empty mean values, whereas a too large short-term duration results in the information loss of the variations in heart rate segments. The resulting smoothed heart rate trajectory is considered appropriate to detect global heart rate patterns associated with COVID-19-like symptoms (red curve in middle of Fig. 1 ). We then transform the averaged heart rate data of each segment into a feature map, i. e., an image of size 24×168 pixels (bottom of Fig. 1 ), in which each pixel represents a 5-minutes heart rate sampling point. Thereby, each column encodes a heart rate trajectory of 2 hours (24 × 5 minutes), resulting in a covered interval of overall 14 days by 168 columns (168 × 2 hours). In our experiments, we verify that this set-up of the feature map is effective as the input of our deep learning models, leading to promising detection results. An approach to learn representations from a feature map is to use a CAE [29] , which contains an encoder to learn latent attributes of the original input, and a decoder for reconstructing the original input from the learnt latent attribute. The dimensionality of the latent attributes is designed as a bottleneck imposed in the architecture. It hence can be seen as a compressed knowledge representation of the input. To reproduce the original input at the output of the decoder, the reconstruction error is minimised when optimising an auto-encoder network. To incorporate the class information during the optimisation, we apply contrastive loss [16] to the CAE reconstruction error in order to guide it to learn sufficiently discriminative latent attributes for different classes. The decoder presents an inverse processing of the encoder. For each decoder layer, the feature map mainly passes through transposed convolution and transposed max-pooling, also known as de-convolution and de-pooling. Batch normalisation is employed in between, followed by PReLU as the activation function. The decoder f dec (·) outputs the reconstructed feature map The specifications of our CAE are given in Table 3 . In experiments, we consider different numbers of convolutional layers in the CAE. The last encoder layer determines the dimensionality of the flatten layer, we hence adjust the length of its following fully-connected layer to optimise the CAE performance. An auto-encoder is typically optimised by minimising the reconstruction error, such as the root mean squared error (RMSE): The difficulty in finding good latent attributes lies in setting it to a proper dimensionality. Too long latent attributes may contain redundancies for easier reconstructing the original input, but fall short of concentrating on learning the saliently discriminative features for different classes. Meanwhile, shorter latent attributes can have less or limited representation capability. Besides, the optimisation of an auto-encoder considers no class information, and hence the learnt latent attributes are not well oriented to be discriminative for different classes. Specifically, for our classification task, the auto-encoder may Table 3 : Specifications of our CAE models. Each convolution and pooling layer, as well as de-convolution and de-pooling layer contains its own kernel size, stride, padding size, and number of channels. *=dimensionality depends on the total number of layers, **= dimensionality of latent attributes. fc abbreviates fully-connected layer. Blocks Kernel Stride Padding # Channels conv1 64 Decoder depool4 (2, 2) (2, 2) − 64 deconv5 (5, 5) (1, 1) (2, 2) 32 depool5 (2, 2) (2, 2) − 32 deconv6 (5, 5) (1, 1) (2, 2) 1 depool6 (2, 2) (2, 2) − 1 tend to learn the latent attributes that can better reconstruct the original feature map, while ignoring some salient attributes that indicate the difference between symptomatic and asymptomatic segments. To incorporate class information -symptomatic and asymptomatic -into the optimisation of CAE, we fit the reconstruction error of the two classes into contrastive loss [16] . As analogues to anomaly detection, we expect the CAE to output a low reconstruction error for asymptomatic segments, and a high reconstruction error for symptomatic segments. Therefore, the loss function for our contrastive CAE can be seen as where the superscripts p and n are used to distinguish positive (symptomatic) and negative (asymptomatic) samples. Ideally, the reconstruction error for a negative pair, i. e., an original and a reconstructed feature map for an asymptomatic segment, is expected to be 0, indicating a successful reconstruction of the original input at the decoder. In contrast, the reconstruction error for a positive input pair, i. e., an original and a reconstructed feature map for a symptomatic segment, is expected to be the margin value m. Therefore, the difference in classes leads to different reconstruction errors from our CAE. We conducted a series of experiments to test the model presented in Section 4. The contrastive CAE was pre-trained with the heart rate segments of 49 participants that reported COVID-19-like symptoms, but did not meet the CD1 or CD2 criterion. We then applied LOSO CV to the heart rate segments of the 19 individuals who meet CD1 or CD2, and their corresponding symptom-free control group. The performance is mainly compared to a CNN of the same architecture of our CAE encoder, and a CAE that is optimised using RMSE loss. Models of different layers are tested using mean unweighted average recall (UAR, chance-level is 50 %), sensitivity, and specificity, the area under receiver oper- The hyper-parameters are selected after careful fine-tuning to assure stable and fast convergence of our models. We first compare our proposed contrastive CAE with MLP and LSTM neural networks [13] directly applied to the one-dimensional 5-min average heart rate segments without formatting it into feature maps (noted as "1D" in Table 4 ). LSTM and CNN are then tested with the two-dimensional formatted feature maps (noted as "2D" in Table 4 ) for fair comparisons. The MLP is found to be best with 4 layers (1000 − 250 − 50 − 20 hidden units of each layer), and its performance is shown in We next compare our proposed CAE using contrastive loss to a conventional CAE using RMSE. We first explore the improvements in learning discriminative latent attributes, and then investigate the approach of applying classification directly on reconstruction errors of constrastive CAE. For each different dimension of latent attributes, a two-layers MLP classifier is separately tuned to project the learnt latent attributes to classes. The conventional CAE reaches its optimum UAR, specificity, and MCC when using the latent attributes of the size of 50, and optimum sensitivity and AUC-ROC when using the latent attributes of the size of 500, as given in Table 5 . Its best performance indicates its limited capability in learning discriminative latent attributes between symptomatic and asymptomatic segments. As it considers no class information when learning latent attributes, it leaves the classification difficulty to the MLP classifiers. The conventional CAE performs even worse than the CNN model, further stressing the need of involving the class information in training a more efficient CAE. For the binary classification task, the classes' difference can be implicitly modelled in the contrastive loss as in Eq. (4) for training the CAE, since the positive and negative reconstruction error are guided to produce a mar- gin between each other in a discriminative manner. Hence, the contrastive CAE is capable of learning latent attributes that represent salient features to distinguish between symptomatic and asymptomatic segments. In our experiments, the contrastive CAE with an attribute dimensionality of 100 achieves its best result in terms of UAR, sensitivity and AUC-ROC, and when the dimensionality increases to 500, the proposed contrastive CAE achieves the best specificity result, and a MCC of 0.247 which considerably outperforms the conventional CAE. Applying classification directly on the reconstruction errors, rather than the learnt latent attributes, is a more efficient way to use the contrastive CAE for our binary decision task. The decision threshold between the reconstruction errors of symptomatic and asymptomatic classes is determined using logistic regression on the training part for each cross-validation round. A 14- criterion) if the reconstruction error is above the decision boundary. The best performance, shown in Table 6 , is achieved with the attributes' length equalling 100, achieving an UAR of 95.3%, a sensitivity of 100.0%, a specificity of 90.6%, an AUC-ROC of 0.944, and a MCC of 0.310. Generally, the contrastive CAE performs stably over different attribute dimensionalities, reducing the difficulty in setting its proper dimensionality. An extreme case is to combine the encoder and decoder by removing the latent attributes layer. The performance, however, maintains stable as given in the last row of Table 6 . Margin size represents the expected distance between the reconstruction errors of positive and negative samples. Ideally, the reconstruction error of a positive input pair is expected to be 0, and that of a negative input pair to the margin m according to Eq. (4). In practice, during the optimisation of provide enough space for setting the decision threshold between the reconstruction errors of symptomatic and asymptomatic segments. The impact of the margin size on classification results can be seen in Table 7 . An interesting phenomenon can be observed for the successful training [30] . In this section, we compare the use of different numbers of participants for pre-training the contrastive CAE. For each considered number of participants for pre-training, we apply random selection of participants. We then pre-train our model using the selected participants while keeping the LOSO CV procedure unchanged for evaluation. We run the selection procedure five times and the average testing results are given in Table 8 . The model turns out to be effective when using at least 30 participants for pre-training. As the number of participants drops below 20, the classification performance declines, revealing the necessity of supplying the model with enough pre-training data to reach its optimal performance. Throughout all previous experiments, we keep assuming that the participant- have higher certainty that symptoms are indeed contained. Therefore, in both cases, our model achieves stable performance. Also, there might be some participants whose symptoms started earlier, and eased soon. In this case, segments that are shifted many days later, may exclude the true symptomatic episode, leading to a low classification performance. We proposed a contrastive CAE to make a machine-learning-based COVID- pre-training was verified by having achieved a reliable performance. In addition, adjusting the margin size within a proper range was shown to be crucial to stable convergence and classification performance. Although the results have been obtained using heart rate estimates provided by Fitbit, they are expected to be generalisable to any other device providing accurate heart rate measurements, and better results could be obtained if the recorded PPG signal is accessible. The efficacy of contrastive CAE demonstrated in this work provides the basis for further research. As representing a general binary classification method, we expect its widespread adoption, especially for the prediction of diseases other than COVID-19. In a departure from conventional unsupervised learning methods for anomaly detection with auto-encoders, we present a self-supervised learning approach by supplying a training target that adapts the model to the objective of anomaly detection during its optimisation. The benefit of this target-oriented optimi-sation strategy should not stay reserved to our COVID-19 yes/no scenario. Since the proposed method introduces an additional parameter, i. e., margin size, the challenge lies in setting a proper margin size for new scenarios. Besides, the proposed model requires an appropriate amount of data for pretraining, which hampers its adoption, e. g., to the detection of rare diseases. In the short term, our proposed contrastive CAE will be extended to multiclass paradigms in order to fit for a wider range of applications. Since the set-up of our experiments was chosen to detect whether or not the COVID-19-like symptoms appeared during a period of recorded heart rate data, the models show limitations in a causal set-up, i. e., when trying to predict potential symptoms before they are present. To this end, future work shall try to answer the question of how many days in advance we can reliably predict the potential imminent onset of COVID-19-like symptoms. As the acquisition of data in the RADAR-CNS programme is still ongoing, the improvement of our proposed binary COVID-19 yes/no (based on the symptom CD1/CD2 definitions above) classification model based on a broader data foundation is expected. Further to that, other windows of time should be analysed. Overall, we are optimistic that an applicable decision can be made as to COVID-19 presence based on the symptoms defined herein based on machine learning analysis of consumer-type heart rate measurement. The rise of consumer health wearables: Promises and barriers RADAR-base: Open source mobile health platform for collecting, monitoring, and analyzing data using sensors, wearables, and mobile devices Deep Learning for IoT big data and streaming analytics: A survey Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: A population-based study Wearable sensor data and selfreported symptoms for COVID-19 detection Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography Automatically discriminating and localizing COVID-19 from community-acquired pneumonia on chest X-rays Heart rate variability in critical care medicine: A systematic review Clinical review: A review and analysis of heart rate variability and the diagnosis and prognosis of infection Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection Assessment of physiological signs associated with COVID-19 measured using wearable devices Pre-symptomatic detection of COVID-19 from smartwatch data Deep learning Supervised autoencoders: Improving generalization performance with unsupervised regularizers Deep learning for anomaly detection: A review Proceedings of the Conference on Neural Information Processing Systems Feasibility of continuous fever monitoring using wearable devices Characterizing COVID-19 and Influenza illnesses in the real world via person-generated health data Exploring automatic diagnosis of COVID-19 from crowdsourced respiratory sound data Computer audition for fighting the SARS-CoV-2 Corona crisis Introducing the multi-task speech corpus for COVID-19 Detection of COVID-19 from speech signal using bio-inspired based cepstral features Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients Use of physiological data from a wearable device to identify SARS-CoV-2 infection and symptoms and predict COVID-19 diagnosis: Observational study MetaCOVID: A Siamese neural network framework with contrastive loss for n-shot diagnosis of COVID-19 patients Momentum contrastive learning for few-shot COVID-19 diagnosis from chest CT images The RADAR-CNS consortium, Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: A multicenter European study Performance evaluation of classification algorithms by kfold and leave-one-out cross validation The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application Stacked denoising autoencoders: Learning useful representations in a deep network with a local denoising criterion Greedy layerwise training of deep networks He is currently a Ph.D candidate at the Chair of Embedded Intelligence for Health Care and Wellbeing Her research interests are deep learning methods for human-centric multimodal affective computing and health care. Estela Laporta Puyal obtained the B.Sc. degree in Telecommunications Engineering and the M.Sc. in the same field Computer Engineering in 2013 and received the Ph.D. degree in Engineering and Applied Sciences in 2019 at University of Bergamo. There, he worked on the RADAR-CNS project as a post-doctoral research fellow until December 2020. Today, Patrick works at Bosch Sensortec as an IMU Sensor Expert As a postdoctoral researcher at the Chair of Embedded Intelligence for Health Care and Wellbeing, University of Augsburg, Germany, and the Division of Phoniatrics Carlos Nos is a neurologist working at the Multiple Sclerosis Center of Catalonia, Vall d'Hebron Barcelona Hospital Campus. His main research interest is Therapeutics and he has been involved in more than 50 international Clinical Trials over the last 25 years He is principal investigator of the Innovative Medicines Initiative's Remote Measurement in Disease and Relapse in CNS conditions (RADAR-CNS) which explores the use of mobile technologies to track and predict health states. Björn Schuller, FIEEE, FISCA, FBCS (h-Index 87, 36k+ citations) is Professor of AI at Imperial College London/UK, Professor and Chair of Embedded Intelligence for Health Care and Wellbeing at the University of Augsburg/Germany This project has received funding from the Innovative Medicines Initia- ☐ The authors declare that they have no known compeng nancial interests or personal relaonships that could have appeared to inuence the work reported in this paper.☐The authors declare the following nancial interests/personal relaonships which may be considered as potenal compeng interests: